- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 02.12. | Bullion Gold Resources Corporation: Bullion Gold Presents the Historical Overview of Its Terragold Gold Project | 313 | Newsfile | Montreal, Quebec--(Newsfile Corp. - December 2, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or "the Corporation") will soon file an ATI permit application for a stripping and drilling... ► Artikel lesen | |
| 26.11. | Bullion Gold Resources Corporation: Bullion Gold Acquires the Transterre, Transterre-Ouest, and Candore Gold Projects (Forming the Terragold Project) | 342 | Newsfile | Montreal, Quebec--(Newsfile Corp. - November 26, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or "the Corporation") is pleased to announce the signing of an acquisition agreement... ► Artikel lesen | |
| BULLION GOLD RESOURCES Aktie jetzt für 0€ handeln | |||||
| 14.11. | Bullion Gold Resources Corp (2): Bullion begins survey at Langlade, appoints director | 1 | Stockwatch | ||
| 13.11. | Bullion Gold Resources Corporation: Bullion Gold Begins Geochemical Survey of Base Till on Langlade and Appoints a New Director to Its Board | 375 | Newsfile | Montreal, Quebec--(Newsfile Corp. - November 13, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or "The Company") is proud to announce the launch of an intensive follow-up program... ► Artikel lesen | |
| 29.10. | Bullion Gold Resources Corp (2): Bullion Gold private placement | 1 | Stockwatch | ||
| 28.10. | Bullion Gold Resources Corporation: 1.7km Gold System Emerging at Decoeur | 362 | Newsfile | Montreal, Quebec--(Newsfile Corp. - October 28, 2025) - Bullion Gold Resources (TSXV: BGD) ("Bullion Gold" or "The Company") is pleased to further assay results have been received for the Decoeur Prospect... ► Artikel lesen | |
| 22.10. | Bullion Gold Resources Corp (2): Bullion hires ITG as market-maker, arranges financing | 1 | Stockwatch | ||
| 21.10. | Bullion Gold Resources Corporation: Bullion Gold Engages Independent Trading Group as Market Maker, Announces Private Placement. | 995 | Newsfile | Montreal, Quebec--(Newsfile Corp. - October 21, 2025) - Bullion Gold Resources (TSXV: BGD) ("Bullion Gold" or "The Company") announces that, subject to regulatory approval, it has engaged the services... ► Artikel lesen | |
| 10.10. | Bullion Gold Resources Corp (2): Bullion Gold identifies Au grains at Cadillac-Extension | 1 | Stockwatch | ||
| 09.10. | Bullion Gold Resources Corporation: Bullion Gold Identifies Coarse, Irregular Gold Grains North of Langlade VMS Prospect (Cadillac-Extension Project), Launches Expanded Basal Till Sampling Program. | 265 | Newsfile | Montreal, Quebec--(Newsfile Corp. - October 9, 2025) - Bullion Gold Resources (TSXV: BGD) ("Bullion Gold" or "The Company") is pleased to announce encouraging preliminary results from a test basal... ► Artikel lesen | |
| 04.10. | Bullion Gold Resources Corp (2): Bullion Gold Resources private placement | 1 | Stockwatch | ||
| 02.10. | Bullion Gold Resources Corp (2): Bullion Gold's Canico samples return up to 2.16 g/t Au | 1 | Stockwatch | ||
| 02.10. | Bullion Gold Resources Corporation: Bullion Gold Confirms a Promising New Polymetallic Showing at Bodo and Identifies a Potential IOCG/SKARN-type Target | 389 | Newsfile | Montreal, Quebec--(Newsfile Corp. - October 2, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") is pleased to announce the confirmation of the polymetallic character... ► Artikel lesen | |
| 30.09. | Bullion Gold Resources Corporation: Bousquet Drilling Demonstrates Down Dip Potential at Paquin | 311 | Newsfile | Montreal, Quebec--(Newsfile Corp. - September 30, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") is pleased to announce that its partner Olympio Metals has just... ► Artikel lesen | |
| 17.09. | Bullion Gold Resources Corp (2): Bullion Gold sets out Quebec project exploration work | 1 | Stockwatch | ||
| 16.09. | Bullion Gold Resources Corporation: Bullion Gold Provides Updates on Its Bousquet, Langlade, and Bodo (Rivon Zone) Exploration Projects | 370 | Newsfile | Montreal, Quebec--(Newsfile Corp. - September 16, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") is pleased to provide an update on the progress of its exploration... ► Artikel lesen | |
| 29.08. | Bullion Gold Resources Corp (2): Bullion Gold samples up to 15.5% Cu, 137 g/t Ag at Bodo | 1 | Stockwatch | ||
| 28.08. | Bullion Gold Resources Corporation: Bullion Samples Up to 15.5% Cu, 137 G/t Ag and 6.85 G/t Au at the Bodo Project and Identifies a New Gold Target at Holton Creek | 398 | Newsfile | Montreal, Quebec--(Newsfile Corp. - August 28, 2025) - Bullion Gold Resource Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") is pleased to announce the first assay results from surface sampling... ► Artikel lesen | |
| 27.08. | Bullion Gold Resources Corp (2): Bullion, Olympio drill 14.5m of 1.96 g/t Au at Bousquet | 1 | Stockwatch | ||
| 26.08. | Bullion Gold Resources Corporation: Continued Success of Bousquet Gold Drilling with First Holes at Decoeur Prospect | 430 | Newsfile | Montreal, Quebec--(Newsfile Corp. - August 26, 2025) - Bullion Gold Resources (TSXV: BGD) ("Bullion Gold" or "The Company") and its partner Olympio Metals Limited ("Olympio") are pleased to announce... ► Artikel lesen |
1 2 3 Weiter >>
45 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| VOR BIOPHARMA | 11,770 | +40,45 % | Vor Biopharma Inc. - 8-K, Current Report | ||
| STRUCTURE THERAPEUTICS | 70,03 | +0,04 % | Structure Therapeutics Inc.: Structure Therapeutics Reports Positive Topline Data from ACCESS Program for its Once-Daily Oral Small Molecule GLP-1 Receptor Agonist, Aleniglipron | Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight... ► Artikel lesen | |
| KYMERA THERAPEUTICS | 86,46 | -8,32 % | Kymera Therapeutics, Inc.: Kymera Therapeutics Announces Positive Results from BroADen Phase 1b Clinical Trial of KT-621, a First-in-Class, Oral STAT6 Degrader, in Patients with Moderate to Severe Atopic Dermatitis | KT-621 achieved deep STAT6 degradation across both the 100 mg and 200 mg dose groups tested, with median reductions of 94% and 98% in skin and blood, respectively, demonstrating strong translation... ► Artikel lesen | |
| EVOTEC | 5,124 | -2,29 % | Kaufchance oder weiterer Absturz? Rheinmetall, Evotec und Rohstoff-Highflyer Pasinex Resources im Aktien-Check | Eine der spannendsten Rohstoff-Aktien derzeit ist wohl Pasinex Resources. Obwohl Zink eher im Schatten anderer Rohstoffe steht, entwickelt sich die Aktie mustergültig. Der Fokus auf hochgradige Projekte... ► Artikel lesen | |
| DYNE THERAPEUTICS | 18,950 | -14,60 % | Dyne Therapeutics, Inc.: Dyne Therapeutics Announces Positive Topline Results from Phase 1/2 DELIVER Trial of Z-Rostudirsen in Duchenne Muscular Dystrophy (DMD) | - Registrational Expansion Cohort (REC) met primary endpoint, demonstrating statistically significant increase in dystrophin to 5.46% at 6 months (muscle content-adjusted; p - Functional improvement... ► Artikel lesen | |
| AVIDITY BIOSCIENCES | 71,41 | +0,22 % | Avidity Biosciences, Inc.: Avidity Biosciences Reports Third Quarter 2025 Financial Results and Recent Highlights | Announced Novartis agreement to acquire Avidity for total equity value of approximately $12 billion; Avidity expects to separate its early-stage precision cardiology... ► Artikel lesen | |
| PRAXIS PRECISION MEDICINES | 259,42 | -4,39 % | Morning Market Movers: SMX, Praxis Precision Medicines, Polyrizon, Rubrik, Inc. See Big Swings | HONG KONG (dpa-AFX) - At 7:50 a.m. ET on Friday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| QIAGEN | 39,465 | -0,82 % | JEFFERIES stuft QIAGEN NV auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Qiagen mit einem Kursziel von 57 US-Dollar auf "Buy" belassen. Die Profitabilität dürfte 2026 zumindest stabil bleiben... ► Artikel lesen | |
| COGENT BIOSCIENCES | 38,790 | -3,87 % | Cogent Biosciences, Inc.: Cogent Biosciences Announces Positive Top-line Results of APEX Trial of Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM) | -- Bezuclastinib demonstrated rapid and deep clinical benefit in AdvSM patients resulting in an objective response rate (CR+CRh+PR+CI) of 57% per mIWG criteria and 80% per PPR criteria -- -- Bezuclastinib... ► Artikel lesen | |
| RECURSION PHARMACEUTICALS | 4,825 | -0,10 % | Recursion Pharmaceuticals, Inc.: Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at 25 Weeks | REC-4881 (4 mg QD) achieved rapid clinical activity, with 75% of evaluable patients showing reductions in total polyp burden and a 43% median reduction after 12 weeks of treatment (n=12)After 12 weeks... ► Artikel lesen | |
| VERA THERAPEUTICS | 44,130 | -2,00 % | Vera Therapeutics announces $200M public offering | ||
| SUMMIT THERAPEUTICS | 17,290 | -7,19 % | Trading Near Its 52-Week Low, Is Summit Therapeutics a Good Stock to Buy Right Now? | ||
| BIONTECH | 82,70 | -1,08 % | Top 5 Adipositas-Aktien: Bayer geht steil, BioNTech fällt und Michael Burry geht auf Tesla los! | Bayer stürmt an die Spitze im DAX. Analysten und Anleger sind begeistert. Die US-Regierung hat sich dafür ausgesprochen, dass das Supreme Court ein Glyphosat-Urteil spricht. Ist das der lang ersehnte... ► Artikel lesen | |
| ARCELLX | 69,77 | -5,82 % | Arcellx, Inc. - 8-K, Current Report | ||
| FULCRUM THERAPEUTICS | 14,845 | +14,19 % | Fulcrum Therapeutics, Inc.: Fulcrum Therapeutics Announces Positive Initial Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting | ? Clear dose-response observed, with a robust and clinically meaningful fetal hemoglobin (HbF) induction at the Week 6 timepoint (n=12): mean absolute HbF in the 20 mg cohort increased by 9.9% at... ► Artikel lesen |
Das Unternehmen BULLION GOLD RESOURCES CORPORATION kann der Branche Biotechnologie zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BULLION GOLD RESOURCES CORPORATION finden Sie auf Wallstreet Online.